Overview

Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines

Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
To describe if there are differences in the subjective, objective and electrophysiologic parameters of diabetic polyneuropathies at baseline, four (4) weeks, eight (8) weeks, and twelve (12) weeks after Cilostazol therapy.
Phase:
Phase 4
Details
Lead Sponsor:
Otsuka Pharmaceutical, Inc., Philippines
Treatments:
Cilostazol